Epstein–Barr Virus and Hemophagocytic Lymphohistiocytosis
Epstein–Barr virus (EBV) is a ubiquitous virus that infects nearly all people worldwide without serious sequela. However, for patients who have genetic diseases which predispose them to the development of hemophagocytic lymphohistiocytosis (HLH), EBV infection is a life-threatening problem. As a par...
Main Author: | Rebecca A. Marsh |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fimmu.2017.01902/full |
Similar Items
-
Epstein-Barr Virus-Induced Hemophagocytic Lymphohistiocytosis
by: K Goudarzipour, et al.
Published: (2013-03-01) -
Epstein-Barr virus induced hemophagocytic lymphohistiocytosis in X-linked lymphoproliferative disease
by: Senthilkumar Sankararaman, et al.
Published: (2014-04-01) -
Epstein-Barr Virus-induced Hemophagocytic Lymphohistiocytosis
by: M. kajiyazdi, et al.
Published: (2013-01-01) -
Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis: response to HLH-04 treatment protocol
by: Elva Jiménez-Hernández, et al.
Published: (2016-01-01) -
PEG-aspargase and DEP regimen combination therapy for refractory Epstein–Barr virus-associated hemophagocytic lymphohistiocytosis
by: Jingshi Wang, et al.
Published: (2016-09-01)